BMJ21h
Musculoskeletal pain in Europe: its impact and a comparison of population and medical perceptions of treatment in eight European countries
Objectives: To describe the impact of musculoskeletal pain (MP); to compare management of MP by the population and by primary care physicians; and to identify misconceptions about treatment. Methods: ...
BMJ12h
AB0697 Giant cell arteritis with normal inflammatory markers at diagnosis
Background GCA is an inflamatory vasculitis affecting medium and large-sized arteries, that can result in arteritic anterior ischaemic optic neuropathy. C-reactive protein (CRP) level and erythocyte ...
BMJ1d
Dysregulated neutrophil responses and neutrophil extracellular trap formation and degradation in PAPA syndrome
Correspondence to Dr Mariana J Kaplan, Systemic Autoimmunity Branch, National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), National Institutes of Health (NIH), Bethesda, MA ...
BMJ2d
Clinical characteristics and outcomes of COVID-19 breakthrough infections among vaccinated patients with systemic autoimmune rheumatic diseases
Correspondence to Dr Zachary Scott Wallace, Division of Rheumatology, Allergy, and Immunology and Clinical Epidemiology Program, Mongan Institute, Department of Medicine, Massachusetts General ...
BMJ5d
2022 American College of Rheumatology/European Alliance of Associations for Rheumatology classification criteria for granulomatosis with polyangiitis
Objective To develop and validate revised classification criteria for granulomatosis with polyangiitis (GPA). Methods Patients with vasculitis or comparator diseases were recruited into an ...
BMJ6d
EULAR recommendations for the management of ANCA-associated vasculitis: 2022 update
Background Since the publication of the EULAR recommendations for the management of antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV) in 2016, several randomised clinical trials ...
BMJ5d
Effect of intensive exercise on patients with active rheumatoid arthritis: a randomised clinical trial
Dr C H M van den Ende, Leiden University Medical Centre, Department of Rheumatology, C4-R, Postbox 9600, 2300 RC Leiden, The Netherlands Email:e.vandenende{at}nivel.nl OBJECTIVE To investigate the ...
BMJ8d
Psoriasis rate is increased by the exposure to TNF inhibition in children with JIA
Objective We aimed to investigate the relationship between tumour necrosis factor inhibitors (TNFi) therapy and the onset of new psoriasis in children with juvenile idiopathic arthritis (JIA) using ...
BMJ2d
POS0328 ENGRAILED 1 COORDINATES CYTOSKELETAL ORGANIZATION TO PROMOTE MYOFIBROBLAST DIFFERENTIATION AND FIBROTIC TISSUE REMODELING
1 Friedrich-Alexander-University Erlangen-Nürnberg (FAU) and University Hospital Erlangen, Department of Internal Medicine 3 - Rheumatology and Immunology, Erlangen, Germany 2 FAU Erlangen-Nürnberg ...
BMJ8d
Lipoma arborescens co-existing with psoriatic arthritis releases tumour necrosis factor alpha and matrix metalloproteinase 3
Correspondence to Professor Iain B McInnes, Division of Immunology, Infection and Inflammation, Faculty of Medicine, University of Glasgow, 120 University Avenue, Glasgow G12 8TA, UK; ...
BMJ8d
Is hormone replacement therapy protective for hand and knee osteoarthritis in women?: The Chingford study
OBJECTIVES To explore whether hormone replacement therapy (HRT) has a protective role for osteoarthritis (OA) of the hand and knee in a cross sectional study of women in the general population.
BMJ6d
The IL1-like cytokine IL33 and its receptor ST2 are abnormally expressed in the affected skin and visceral organs of patients with systemic sclerosis
1 Department of Anatomy, Histology and Forensic Medicine, University of Florence, Florence, Italy 2 Department of Biomedicine, Division of Rheumatology, AOUC, and Excellence Centre for Research, ...